𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biologic and Immunomodulator Therapy Improves Depressive Symptoms in Subjects With Inflammatory Bowel Disease

✍ Scribed by Horst, Sara N. ;Gaines, Lawrence S. ;Rosen, Michael J. ;Duley, Caroline ;Wagnon, Julianne H. ;Walker, Lynn S. ;Beaulieu, Dawn B. ;Schwartz, David A.

Book ID
123088049
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
90 KB
Volume
140
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stopping immunomodulators and biologics
Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission
✍ Kofi Clarke; Miguel Regueiro πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

The emergence of biologic response modifiers and earlier use of immunomodulators for inflammatory bowel disease (IBD) patients have improved outcomes. Durable remissions have been achieved in many IBD patients on these treatments, but the duration of treatment and identifying which patients may stop

Vaccination strategies for patients with
Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
✍ Gil Y. Melmed πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

The treatment of Crohn's disease and ulcerative colitis frequently includes potent immunomodulator and biologic therapy to reduce intestinal inflammation, heal fistulae, limit complications, and improve quality of life. These medications may increase susceptibility to and severity of infections, man